Found: 6
Select item for more details and to access through your institution.
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial—Study Design and Protocol.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 6, p. 1461, doi. 10.1007/s13300-024-01582-x
- By:
- Publication type:
- Article
Expert Opinion on the Therapeutic Use of the Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 4, p. 1029, doi. 10.1007/s13300-020-00777-2
- By:
- Publication type:
- Article
Simplifying Complex Insulin Regimens While Preserving Good Glycemic Control in Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 5, p. 1869, doi. 10.1007/s13300-019-0673-8
- By:
- Publication type:
- Article
Prevalence of Respiratory Symptoms and Diseases Associated with Gastroesophageal Reflux Disease.
- Published in:
- Digestion, 2005, v. 71, n. 2, p. 92, doi. 10.1159/000084524
- By:
- Publication type:
- Article
Az elhízás, a 2-es típusú diabetes és a daganatok közötti genetikai összefüggések egy perspektívája: Az FTO és TCF7L2 génpolimorfizmusok lehetséges szerepe.
- Published in:
- Hungarian Medical Journal / Orvosi Hetilap, 2024, v. 165, n. 13, p. 499, doi. 10.1556/650.2024.33011
- By:
- Publication type:
- Article
One‐year safety and efficacy results of insulin treatment simplification with IDegLira in type 2 diabetes.
- Published in:
- Endocrinology, Diabetes & Metabolism, 2023, v. 6, n. 1, p. 1, doi. 10.1002/edm2.390
- By:
- Publication type:
- Article